Dr. KANG Evangeline Tze Zhen
Research Output
- 2022
- Published
Lrwd1 impacts cell proliferation and the silencing of repetitive DNA elements
Kang, T. Z. E., Wan, Y. C. E., Zhang, Z. & Chan, K. M., May 2022, In: Genesis. 60, 4-5, e23475.Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Scopus citations: 2 - 2021
- Published
The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancer
Kang, T. Z. E., Zhu, L., Yang, D., Ding, D., Zhu, X., Wan, Y. C. E. & Liu, J. & 9 others, , 2021, In: Journal of Biological Chemistry. 296, p. 1-15 100374.Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Scopus citations: 20 - 2020
- Published
Cancer-associated histone mutation H2BG53D disrupts DNA-histone octamer interaction and promotes oncogenic phenotypes
Wan, Y. C. E., Leung, T. C. S., Ding, D., Sun, X., Liu, J., Zhu, L. & Kang, T. Z. E. & 13 others, , 2020, In: Signal Transduction and Targeted Therapy. 5, 27.Research output: Journal Publications and Reviews › Letter › peer-review
Scopus citations: 23 - Published
The H2BG53D oncohistone directly upregulates ANXA3 transcription and enhances cell migration in pancreatic ductal adenocarcinoma
Wan, Y. C. E., Liu, J., Zhu, L., Kang, T. Z. E., Zhu, X., Lis, J. & Ishibashi, T. & 3 others, , 2020, In: Signal Transduction and Targeted Therapy. 5, 106.Research output: Journal Publications and Reviews › Letter › peer-review
Scopus citations: 12